antiviral drugs antiviral drugs
Stories About

antiviral drugs

Kyle Planck, who has recovered from a painful case of monkeypox, has joined advocacy groups and pleaded with elected officials to make the antiviral pills TPOXX more available. Yuki Iwamura/AFP via Getty Images hide caption

toggle caption
Yuki Iwamura/AFP via Getty Images

Getting monkeypox treatment is easier, but still daunting and confusing

  • <iframe src="https://www.npr.org/player/embed/1114509291/1114521413" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Molnupiravir, an antiviral drug to treat mild to moderate COVID-19, is under consideration by the FDA for possible authorization. Merck hide caption

toggle caption
Merck

Molnupiravir, an antiviral drug to treat mild to moderate COVID-19, is under consideration by the FDA for possible authorization. Merck hide caption

toggle caption
Merck

New antiviral drugs are coming for COVID. Here's what you need to know

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1059926089/1060212486" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript